Various toxicities: 3 case reports

This is a preview of subscription content, access via your institution.


  1. Kriulin I, et al. Secukinumab efficacy and safety in Juvenile Idiopathic Arthritis. Pediatric Rheumatology 18 (Suppl. 2): 73 abstr. P268, 2020. Available from: URL: [abstract]

Download references

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Secukinumab. Reactions Weekly 1840, 333 (2021).

Download citation